Substance Abuse Treatment Market Research Report – Global Forecast till 2023

Substance Abuse Treatment Market Research Report: By Abuse Type (Alcohol Dependence, Tobacco & Drug Abuse, Treatment (Alcohol Addiction (Disulfiram, Acamprosate, & others), Nicotine Addiction & Drug Abuse))), End User – Global Forecast Till 2023

ID: MRFR/HC/5763-HCR | February 2021 | Region: Global | 90 pages

Market Scenario


Global substance abuse treatment market is expected to grow significantly over the forecast period. It is projected to grow at a CAGR of 11.6% over the forecast period. 


Substance abuse refers to the harmful use of psychoactive substances, including alcohol and illicit drugs.


Increasing trends of cigarette smoking in teenagers is one of the prominent factors driving the Substance Abuse Treatment market. According to the 2015 study published in the Clinical and Translational Investigation journal, More than 60% of individuals start smoking at the age of 13 and more than 90% individuals start smoking before reaching 20 years. It is also reported that 5.8% of the Mexican population comprises adolescents between 13 and 15 years. Of them, 42.8% tried a cigarette at some point in their life.


Various other factors such as increasing incidence of drug addiction, technological advancement in the diagnostics industry, rising patient awareness about substance abuse treatment and improvement in treatment rates and healthcare infrastructure are also expected to propel the growth of the market.


However, poor treatment compliance in some countries and reluctance of individuals for accessing treatment can hamper the market growth over the forecast period.


Segmentation


The global substance abuse treatment market is segmented based on abuse type, treatment type, end user, and region.


The global market for substance abuse treatment, by abuse type is segmented into alcohol dependence, tobacco/nicotine addiction, and drug abuse. The drug abuse segment is anticipated to hold the largest market share owing to the increasing addiction of opioid.


The market, by treatment type, is segmented into alcohol addiction treatment, tobacco/nicotine addiction treatment, and drug abuse treatment. The alcohol addiction treatment segment is further classified as disulfiram, acamprosate, and naltrexone. The tobacco/nicotine addiction treatment segment is further classified as nicotine replacement treatment, and non-nicotine medication. The nicotine replacement treatment segment includes nicotine patch, nicotine gum, nicotine lozenge, nicotine spray, and nicotine inhaler. The non-nicotine medication segment includes bupropion, and varenicline. The drug abuse treatment segment is further classified as methadone, buprenorphine, and naltrexone.


Based on end user, the market is segmented into outpatient treatment centres, residential treatment centres, and inpatient treatment centres.


In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region.


The substance abuse treatment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European substance abuse treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The substance abuse treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The substance abuse treatment market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Substance Abuse Treatment market Share (%), by Region, 2017



Sources: MRFR Analysis


The Americas dominated the global market for substance abuse treatment owing to presence of major market players and rising awareness about substance abuse treatment within the region. In recent years, various private and government organizations have launched campaigns and seminar to spread awareness about substance abuse. For instance, in February 2017, the Ad Council and Viacom have launched the LISTEN campaign and a new PSA to address America’s substance abuse crisis.


In 2017, it was estimated that Europe stood second in the global substance abuse treatment market. This can be attributed to the rising research and development investments.


Asia Pacific was projected to be the fastest growing region in 2017. Factors such as increasing incidences of tobacco addiction and increasing technological advancements within the region are boosting the regional markets of the Asia Pacific region. According to the information published in the Frontiers in Psychiatry journal, China is facing an immense public health challenge from tobacco smoking. It is estimated that number of deaths, due to cigarette smoking, will reach 2 million by 2030 and 3 million by 2050.


On the other hand, the Middle East and Africa held least share in the global substance abuse treatment market due to the low per capita income, especially within the African region.


Key players


Some of the key players in the global substance abuse treatment market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., Purdue Pharma LP, Allergan, Mylan Laboratories, Reckitt Benckiser Pharmaceuticals, Teva Pharmaceuticals, Forest Laboratories, Inc., Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharmaceuticals, and others.


Research Methodology


Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.



  • Primary Research


Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the substance abuse treatment. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.


Intended Audience



  • Pharmaceutical Companies

  • Government and Private Laboratories

  • Research and Development (R&D) companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers


Market Segmentation and Key Market Players


Global Substance Abuse Treatment Market, by Abuse Type



  • Alcohol Dependence

  • Tobacco/Nicotine Addiction

  • Drug Abuse

  • Others


Global Substance Abuse Treatment Market, by Treatment Type



  • Alcohol Addiction Treatment

    • Disulfiram

    • Acamprosate

    • Naltrexone



  • Tobacco/Nicotine Addiction Treatment

    • Nicotine Replacement Treatment

      • Nicotine Patch

      • Nicotine Gum

      • Nicotine Lozenge

      • Nicotine Spray

      • Nicotine Inhaler



    • Non-Nicotine Medication

      • Bupropion

      • Varenicline





  • Drug Abuse Treatment

    • Methadone

    • Buprenorphine

    • Naltrexone




Global Substance Abuse Treatment Market, by End User



  • Outpatient Treatment Centers

  • Residential Treatment Centers

  • Inpatient Treatment Centers



Frequently Asked Questions (FAQ) :


Global Substance Abuse Treatment Market would record a CAGR of 11.6% during the forecast period of 2018 to 2023.

Global Substance Abuse Treatment Market would face poor treatment compliances as a major market distraction.

Americas would dominate the global Substance Abuse Treatment Market.

Sectors like outpatient treatment centers, residential treatment centers, and inpatient treatment centers are the end users.

Asia Pacific region would be the fastest-growing in the global Substance Abuse Treatment Market.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Substance Abuse Treatment Market, by Abuse Type

6.1 Introduction

6.2 Alcohol Dependence

6.3 Tobacco/Nicotine Addiction

6.4 Drug Abuse

6.5 Others

Chapter 7. Global Substance Abuse Treatment Market, by Treatment Type

7.1 Introduction

7.2 Alcohol Addiction Treatment

7.2.1 Disulfiram

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.2.2 Acamprosate

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.2.3 Naltrexone

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023
7.3 Tobacco/Nicotine Addiction Treatment

7.3.1 Nicotine Replacement Treatment

7.3.1.1 Nicotine Patch

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3.1.2 Nicotine Gum

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3.1.3 Nicotine Lozenge

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3.1.4 Nicotine Spray

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3.1.5 Nicotine Inhaler

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3.2 Non-Nicotine Medication

7.3.2.1 Bupropion

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3.2.2 Varenicline

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.4 Drug Abuse Treatment

7.4.2.1 Methadone

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.4.2.2 Buprenorphine

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.4.2.3 Naltrexone

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 8. Global Substance Abuse Treatment Market, by End User

8.1 Introduction

8.2 Outpatient Treatment Centers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3 Residential Treatment Centers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Inpatient Treatment Centers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023
Chapter 9. Global Substance Abuse Treatment Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Pfizer Inc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Alkermes Plc

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 GlaxoSmithKline Plc.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Purdue Pharma LP

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Allergan

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Mylan Laboratories

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Reckitt Benckiser Pharmaceuticals,

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Teva Pharmaceuticals

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Forest Laboratories, Inc.

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Accord Healthcare

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Amphastar Pharmaceuticals

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Apotex

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 BioCorRx

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Cipla

11.14.1 Overview

11.14.2 Product Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Sun Pharmaceuticals

11.15.1 Overview

11.15.2 Product Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

11.16 Other

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictionsfor the global substance abuse treatment market

Chapter 13. Appendix

LIST OF TABLES

Table 1 Substance Abuse Treatment Market Synopsis, 2018–2023

Table 2 Substance Abuse Treatment Market Estimates and Forecast, 2018–2023 (USD Million)

Table 3 Global Substance Abuse Treatment Market, by Region, 2018–2023 (USD Million)

Table 4 Global Substance Abuse Treatment Market, by Abuse Type, 2018–2023 (USD Million)

Table 5 Global Substance Abuse Treatment Market, by Treatment Type, 2018–2023 (USD Million)

Table 6 Global Substance Abuse Treatment Market, End User, 2018–2023 (USD Million)

Table 7 North America: Substance Abuse Treatment Market, by Abuse Type, 2018–2023 (USD Million)

Table 8 North America: Substance Abuse Treatment Market, by Treatment Type, 2018–2023(USD Million)

Table 9 North America: Substance Abuse Treatment Market, End User, 2018–2023 (USDMillion)

Table 10 US: Substance Abuse Treatment Market, by Abuse Type, 2018–2023 (USD Million)

Table 11 US: Substance Abuse Treatment Market, by Treatment Type, 2018–2023 (USD Million)

Table 12 US: Substance Abuse Treatment Market, End User, 2018–2023 (USD Million)

Table 13 Canada:Substance Abuse Treatment Market,byAbuse Type, 2018–2023 (USD Million)

Table 14 Canada: Substance Abuse Treatment Market, by Treatment Type, 2018–2023 (USD Million)

Table 15 Canada: Substance Abuse Treatment Market, End User, 2018–2023 (USDMillion)

Table 16 South America: Substance Abuse Treatment Market, by Abuse Type, 2018–2023 (USD Million)

Table 17 South America: Substance Abuse Treatment Market, by Treatment Type, 2018–2023 (USD Million)

Table 18 South America: Substance Abuse Treatment Market, End User, 2018–2023 (USDMillion)

Table 19 Europe: Substance Abuse Treatment Market, by Abuse Type, 2018–2023 (USD Million)

Table 20 Europe: Substance Abuse Treatment Market, by Treatment Type, 2018–2023 (USD Million)

Table 21 Europe: Substance Abuse Treatment Market, End User, 2018–2023 (USD Million)

Table 22 Western Europe: Substance Abuse Treatment Market, by Abuse Type, 2018–2023 (USDMillion)

Table 23 Western Europe: Substance Abuse Treatment Market, by Treatment Type, 2018–2023 (USD Million)

Table 24 Western Europe: Substance Abuse Treatment Market, by End User, 2018–2023(USD Million)

Table 25 Eastern Europe: Substance Abuse Treatment Market, by Abuse Type, 2018–2023 (USD Million)

Table 26 Eastern Europe: Substance Abuse Treatment Market, by Treatment Type, 2018–2023 (USD Million)

Table 27 Eastern Europe: Substance Abuse Treatment Market, End User, 2018–2023(USD Million)

Table 28 Asia-Pacific: Substance Abuse Treatment Market, by Abuse Type, 2018–2023 (USD Million)

Table 29 Asia-Pacific: Substance Abuse Treatment Market,by Treatment Type, 2018–2023 (USD Million)

Table 30 Asia-Pacific: Substance Abuse Treatment Market, End User, 2018–2023 (USD Million)

Table 31 Middle East & Africa: Substance Abuse Treatment Market, by Abuse Type, 2018–2023 (USD Million)

Table 32 Middle East & Africa: Substance Abuse Treatment Market, by Treatment Type,2018–2023 (USD Million)

Table 33 Middle East & Africa: Substance Abuse Treatment Market, End User, 2018–2023(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Substance Abuse Treatment Market

Figure 3 Market Dynamics for Global Substance Abuse Treatment Market

Figure 4 Substance Abuse Treatment Market Share, by Abuse Type,2017

Figure 5 Substance Abuse Treatment Market Share, by Treatment Type,2017

Figure 6 Substance Abuse Treatment Market Share, End User, 2017

Figure 7 Substance Abuse Treatment Market Share, by Region, 2017

Figure 8 North America: Substance Abuse Treatment Market Share, by Country, 2017

Figure 9 Europe: Substance Abuse Treatment Market Share, by Country, 2017

Figure 10 Asia-Pacific: Substance Abuse Treatment Market Share, by Country, 2017

Figure 11 Middle East & Africa: Substance Abuse Treatment Market Share, by Region, 2017

Figure 12 Substance Abuse Treatment Market : Company Share Analysis, 2017 (%)

Figure 13 Pfizer Inc.: Key Financials

Figure 14 Pfizer Inc.: Segmental Revenue

Figure 15 Pfizer Inc.: Geographical Revenue

Figure 16 Alkermes Plc : Key Financials

Figure 17 Alkermes Plc : Segmental Revenue

Figure 18 Alkermes Plc : Geographical Revenue

Figure 19 GlaxoSmithKline Plc.:Key Financials

Figure 20 GlaxoSmithKline Plc.: Segmental Revenue

Figure 21 GlaxoSmithKline Plc.: Geographical Revenue

Figure 22 Purdue Pharma LP: Key Financials

Figure 23 Purdue Pharma LP: Segmental Revenue

Figure 24 Purdue Pharma LP: Geographical Revenue

Figure 25 Allergan:Key Financials

Figure 26 Allergan: Segmental Revenue

Figure 27 Allergan: Geographical Revenue

Figure 28 Mylan Laboratories: Key Financials

Figure 29 Mylan Laboratories: Segmental Revenue

Figure 30 Mylan Laboratories: Geographical Revenue

Figure 31 Reckitt Benckiser Pharmaceuticals, : Key Financials

Figure 32 Reckitt Benckiser Pharmaceuticals, : Segmental Revenue

Figure 33 Reckitt Benckiser Pharmaceuticals, : Geographical Revenue

Figure 34 Teva Pharmaceuticals:Key Financials

Figure 35 Teva Pharmaceuticals: Segmental Revenue

Figure 36 Teva Pharmaceuticals: Geographical Revenue

Figure 37 Forest Laboratories, Inc.: Key Financials

Figure 38 Forest Laboratories, Inc.: Segmental Revenue

Figure 39 Forest Laboratories, Inc.: Geographical Revenue

Figure 40 Accord Healthcare: Key Financials

Figure 41 Accord Healthcare: Segmental Revenue

Figure 42 Accord Healthcare: Geographical Revenue

Figure 43 Amphastar Pharmaceuticals : Key Financials

Figure 44 Amphastar Pharmaceuticals :Segmental Revenue

Figure 45 Amphastar Pharmaceuticals : Geographical Revenue

Figure 46 Apotex: Key Financials

Figure 47 Apotex: Segmental Revenue

Figure 48 Apotex: Geographical Revenue

Figure 49 BioCorRx: Key Financials

Figure 50 BioCorRx: Segmental Revenue

Figure 51 BioCorRx: Geographical Revenue

Figure 52 Cipla: Key Financials

Figure 53 Cipla: Segmental Revenue

Figure 54 Cipla: Geographical Revenue

Figure 55 Sun Pharmaceuticals: Key Financials

Figure 56 Sun Pharmaceuticals: Segmental Revenue

Figure 57 Sun Pharmaceuticals: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.